Yersinia pestis

Yersinia pestis
Name	Yersinia pestis
Caption	Yersinia pestis bacteria (fluorescent stain)
Field	Infectious disease (medical specialty), Microbiology

Yersinia pestis. It is a Gram-negative, non-motile, rod-shaped bacterium belonging to the family Yersiniaceae and is the etiological agent of plague. Historically, it is infamous for causing three major pandemics: the Plague of Justinian, the Black Death, and the Third plague pandemic. The bacterium is primarily a zoonotic pathogen, maintained in rodent populations and transmitted to humans via the bite of infected fleas, most notably those from the genus Xenopsylla cheopis.

Overview and history

The organism was first isolated and identified in 1894 during the Hong Kong plague outbreak by the Swiss-French physician Alexandre Yersin, working at the Pasteur Institute, and independently by the Japanese physician Kitasato Shibasaburō. Its historical impact is profound, with the Black Death in the 14th century devastating populations across Europe, Asia, and Africa, significantly altering the course of Medieval history. The Third plague pandemic, originating in Yunnan in the mid-19th century, spread globally via steamship routes, leading to major outbreaks in port cities like San Francisco and Bombay. The study of ancient DNA has confirmed its presence in victims from the Plague of Justinian and from London burial sites.

Microbiology and genetics

It is a facultative anaerobic organism that grows optimally at 28°C. It is a member of the Enterobacterales order and is closely related to the enteric pathogen Yersinia pseudotuberculosis, from which it evolved roughly 1,500-6,400 years ago. Key genetic features include the presence of three virulence plasmids: pPCP1, pMT1, and pCD1. The chromosome also contains a high-pathogenicity island, which is critical for iron acquisition. The bacterium exhibits a characteristic bipolar staining, giving it a "safety-pin" appearance when stained with Wayson stain or Giemsa stain. Genomic studies, including work by the Sanger Institute, have traced its evolutionary lineage and identified key mutations that increased its virulence and transmissibility.

Pathogenesis and virulence

Primary virulence factors are encoded on the plasmids. The pCD1 plasmid encodes a type III secretion system, known as the Yersinia outer protein (Yop) virulon, which injects effector proteins into host cells, disrupting phagocytosis and immune response. The pMT1 plasmid produces the F1 capsular antigen, which is antiphagocytic, and the murine toxin. The pPCP1 plasmid encodes the protease Pla, which is crucial for systemic spread from subcutaneous sites. The bacterium can survive and multiply inside macrophages, using them as vehicles to disseminate to the lymph nodes, causing the characteristic buboes. Its ability to form biofilms in the proventriculus of the flea vector blocks feeding, enhancing transmission.

Clinical manifestations and diagnosis

Infection manifests in three primary clinical forms: bubonic, septicemic, and pneumonic plague. Bubonic plague, the most common, presents with sudden fever, headache, and painfully swollen lymph nodes (buboes), typically in the groin, axilla, or cervical lymph nodes. Septicemic plague involves bloodstream infection without buboes and can cause disseminated intravascular coagulation and gangrene. Pneumonic plague is a severe pneumonia that is highly contagious via respiratory droplets. Diagnosis is confirmed by culturing the bacterium from samples of blood, sputum, or aspirate from a bubo. Rapid tests, such as immunochromatographic assays for the F1 antigen, are used in field settings. Laboratories like the Centers for Disease Control and Prevention handle confirmatory testing.

Treatment and prevention

Prompt antibiotic therapy is essential to reduce mortality. Historically, streptomycin has been the drug of choice, but gentamicin, doxycycline, and ciprofloxacin are also effective. For post-exposure prophylaxis or treatment of pneumonic plague, levofloxacin or moxifloxacin may be used. Prevention strategies include controlling rodent populations, using insect repellents, and administering prophylactic antibiotics to close contacts of cases. A killed whole-cell vaccine was used historically but offered limited protection and is no longer available. Research into modern subunit vaccines, targeting the F1 and V antigens, is ongoing at institutions like the United States Army Medical Research Institute of Infectious Diseases.

Epidemiology and outbreaks

The bacterium is enzootic in rodent populations on every continent except Australia and Antarctica. Major natural foci exist in Madagascar, the Democratic Republic of the Congo, Peru, and the southwestern United States. Outbreaks are often associated with factors that bring rodents into closer contact with humans. Notable modern outbreaks include the 1994 epidemic in Surat, India, and recurrent seasonal outbreaks in Madagascar. The World Health Organization classifies plague as a re-emerging disease. Due to its high virulence and potential for aerosol transmission, it is classified as a Tier 1 select agent by the U.S. Department of Health and Human Services and is considered a potential agent of bioterrorism.

Category:Pathogenic bacteria Category:Zoonotic bacterial diseases Category:Biological weapons